Publication
CBCA corporations must file information on individuals with significant control starting January 22
Author:
Canada | Publication | December 8, 2023
Starting on January 22, 2024, corporations under the Canada Business Corporations Act (CBCA) that are required to maintain a register of individuals with significant control (ISCs) will have to file that information with the director under the CBCA. Information on ISCs will have to be filed (1) annually, (2) within 15 days after recording a change to the register and (3) following any incorporation, amalgamation or continuance under the CBCA.
Corporations Canada has advised that the annual filing of the ISC information must be made at the same time as the filing of a corporation’s annual return. Annual returns must be filed within 60 days of a corporation’s anniversary date (the date on which the corporation was incorporated or otherwise came into existence under the CBCA) not its year end.
The director will not be required to make information about an ISC public immediately, but that will change once pending amendments to the CBCA are proclaimed in force. Law enforcement agencies and the Financial Transactions and Reports Analysis Centre of Canada will have access to information on ISCs filed with the director.
The information that must be filed with the director starting on January 22, 2024, is set out here.
Information that may be made public | Information that will not be made public |
---|---|
|
|
For further information on ISC registers see our previous client legal update here.
Recent publications
Publication
The GCR Guide to Life Sciences – Product denigration
Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .